These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9613114)

  • 1. [Development of in situ TRAP assay detecting telomerase activity in cell].
    Ohyashiki K; Yahata N; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1159-64. PubMed ID: 9613114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of telomerase activity and its clinical application].
    Ohyashiki K; Ohyashiki JH; Yahata N; Toyama K
    Rinsho Byori; 1997 Dec; 45(12):1133-41. PubMed ID: 9437893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The advantage of an in situ TRAP assay for the detection of telomerase activity using bronchial washings obtained from lung cancer patients].
    Yahata N; Ohyashiki K; Kato H; Toyama K
    Nihon Rinsho; 1998 May; 56(5):1272-7. PubMed ID: 9613136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telomerase activity and determination of cancer in urological neoplasias using exfoliated urinary cells: in situ TRAP assay and its application].
    Ohyashiki K; Yahata N; Iwama H; Aizawa T; Miki M
    Nihon Rinsho; 1998 May; 56(5):1299-303. PubMed ID: 9613141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Telomerase as a tumor marker?].
    Hummel M; Heine B; Demel G; Stein H
    Verh Dtsch Ges Pathol; 1997; 81():312-7. PubMed ID: 9474885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.
    Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; Kato H; Wright WE; Shay JW
    Cancer Res; 1997 Jun; 57(11):2100-3. PubMed ID: 9187102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
    Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
    Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Telomerase activity of common malignant tumors].
    Liu X; Zou Y; Guo C
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):25-7. PubMed ID: 11783063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
    Wei L; Guo Y; Yan Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.
    Herbert BS; Hochreiter AE; Wright WE; Shay JW
    Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
    Naritoku WY; Datar RH; Li P; Groshen SL; Taylor CR; Imam SA
    Cancer; 1999 Aug; 87(4):210-5. PubMed ID: 10455209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of telomerase activity by the TRAP assay and its variants and alternatives.
    Fajkus J
    Clin Chim Acta; 2006 Sep; 371(1-2):25-31. PubMed ID: 16616059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods of measuring telomere length and telomerase activity--practice and problems].
    Saito Y; Suda T; Hatakeyama K
    Nihon Rinsho; 1998 May; 56(5):1153-8. PubMed ID: 9613113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Techniques for detection of telomerase activity in tissue samples. Diagnostic and prognosis importance].
    Brousset P; al Saati T; Chaouche N; Zenou RC; Mazerolles C; Delsol G
    Ann Pathol; 1997 Oct; 17(5):364-8. PubMed ID: 9471158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
    Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
    Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
    Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified telomeric repeat amplification protocol.
    Liu Y; Wu BQ; Zhong HH; Xu ML; Fang WG
    Pathol Int; 2010 May; 60(5):386-94. PubMed ID: 20518889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs.
    Biller BJ; Kitchell BE; Cadile CD
    Am J Vet Res; 1998 Dec; 59(12):1526-9. PubMed ID: 9858400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.